Inspire Medical Systems (INSP) vs Neogen (NEOG)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Neogen (NEOG) has outperformed Inspire Medical Systems (INSP) over the past year, gaining 101.2% versus a loss of 15.1%. Over five years, NEOG leads with a -71.5% price change compared with -72.8% for INSP. Neogen is the larger company by market cap ($2.61 billion vs $2.00 billion), about 1.3 times the size, while Inspire Medical Systems is growing revenue faster (+13.6% vs -2.7%).
On valuation, Neogen trades at a lower forward P/E (31.4x vs 44.9x for Inspire Medical Systems). Inspire Medical Systems converts more of its revenue into profit, with a net margin of 15.9% versus -0.9%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | INSP | NEOG |
|---|---|---|
| Share price | $69.32 | $11.95 |
| Market cap | $2.00B | $2.61B |
| 1-day change | +3.94% | +2.05% |
| YTD return | -27.69% | +67.53% |
| 1-year return | -15.09% | +101.20% |
| 5-year return | -72.80% | -71.47% |
| P/E ratio (TTM) | 15.27 | — |
| Forward P/E | 44.87 | 31.45 |
| EPS (TTM) | $4.54 | $-0.26 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $911.98M | $870.40M |
| Revenue growth (YoY) | +13.60% | -2.72% |
| Net income (latest FY) | $145.42M | $-7.90M |
| Gross margin | 85.39% | 46.93% |
| Operating margin | 5.59% | -2.48% |
| Net margin | 15.95% | -0.91% |
| 52-week high | $147.03 | $14.26 |
| 52-week low | $38.91 | $5.37 |
| Distance from 52-week high | -52.85% | -16.20% |
| Analyst consensus | hold | buy |
| Avg. price target upside | -6.23% | +17.15% |
| Average volume | 798.17K | 3.14M |
| Shares outstanding | 28.91M | 218.31M |
| Employees | 1,333 | 2,636 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- NEOG has outperformed INSP by 116.3 percentage points over the past year.
- Inspire Medical Systems is more profitable, keeping 15.9 cents of every revenue dollar as net income versus -0.9 cents for Neogen.
- Inspire Medical Systems grew revenue faster in its latest fiscal year (+13.60% vs -2.72%).
About Inspire Medical Systems
INSP stock →Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA.
Health Care · Medical/Dental Instruments · 1,333 employees
About Neogen
NEOG stock →Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through Food Safety and Animal Safety segments.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances · 2,636 employees
INSP vs NEOG FAQ
Which is bigger, Inspire Medical Systems or Neogen?
Neogen (NEOG) is larger, with a market capitalization of $2.61B compared with $2.00B for Inspire Medical Systems (INSP).
Which stock has performed better over the past year, INSP or NEOG?
NEOG returned +101.20% over the past 12 months, compared with -15.09% for INSP (price return, excluding dividends). Past performance does not predict future results.
Are Inspire Medical Systems and Neogen in the same industry?
Both are in the Health Care sector, but in different industries: Medical/Dental Instruments for Inspire Medical Systems and Biotechnology: In Vitro & In Vivo Diagnostic Substances for Neogen.